In recent years, the advent of immune checkpoint blockade (ICB) targeting programmed death-1 (PD-1), programmed death ligand-1 (PD-L1), and cytotoxic T lymphocyte-associated protein-4 (CTLA-4) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results